IPBS is a partner in two new Horizon Europe-funded collaborative projects to accelerate the fight against tuberculosis
The ITHEMYC and TBVAC-HORIZON projects have been selected for funding by the European Commission’s Horizon[…]
Carlo Arrelano, resident at the Toulouse Hospitals, is awarded one of the Hélène Starck Prizes of the ARC Foundation for Cancer Research
Within the framework of its research on infectious diseases and cancer, the IPBS regularly welcomes[…]
Ophélie Dufrancais and Marie Rebeaud receive MINERVA trophies from the F•INICIATIVAS Foundation
Ophélie Dufrançais is currently a 4th year PhD student in the team “Phagocyte architecture and[…]
Could a well-known antidepressant prevent severe forms of COVID-19?
In the context of the emergence of new variants of SARS-CoV-2, increasingly resistant to vaccines[…]
Jean-Philippe Girard is among the Highly Cited Researchers 2022 in the Immunology category
Specialist in the analysis of scientific production, Clarivate identifies each year the most influential researchers[…]
Etienne Meunier is awarded the CNRS bronze medal 2022
The Bronze Medal is awarded to researchers who are specialists in their field. This distinction[…]
How T cells discriminate between antigens of different affinities
T lymphocytes are essential cells of the immune system, and have the ability to detect[…]
Metal efflux platforms in the membrane of bacteria
Scientists have discovered a novel mechanism of resistance to metal intoxication in macrophages involving mobile[…]
IPBS teams receive six grants from the French National Research Agency
Towards novel anti-TB drugs With 1.4 million deaths and 10 million new cases each year,[…]
Fight against tuberculosis: the structure of an important target unravelled
Despite its importance as a therapeutic target against tuberculosis, the structure of Pks13 (PolyKetide Synthase[…]